risperidone has been researched along with Nervous System Disorders in 4 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This is because of their efficacy in the treatment of several psychiatric disorders, ease of administration, and absence of the well-known extrapyramidal adverse effects long-attributed to the standard dopamine blocking anti-psychotic medications." | 2.42 | Atypical psychotropic medications and their adverse effects: a review for the African-American primary care physician. ( Bailey, RK, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kar, SK | 1 |
| Saxena, S | 1 |
| Trivedi, JK | 1 |
| Howland, RH | 1 |
| Bailey, RK | 1 |
| Bersani, G | 1 |
| Gherardelli, S | 1 |
| Clemente, R | 1 |
| Di Giannantonio, M | 1 |
| Grilli, A | 1 |
| Conti, CM | 1 |
| Exton, MS | 1 |
| Conti, P | 1 |
| Doyle, R | 1 |
| Pancheri, P | 1 |
1 review available for risperidone and Nervous System Disorders
| Article | Year |
|---|---|
Atypical psychotropic medications and their adverse effects: a review for the African-American primary care physician.
Topics: Adult; Aged; Antipsychotic Agents; Arrhythmias, Cardiac; Benzodiazepines; Black or African American; | 2003 |
3 other studies available for risperidone and Nervous System Disorders
| Article | Year |
|---|---|
Electroconvulsive treatment in catatonia of cerebrovasculo-coagulopathy: a case report.
Topics: Adult; Antipsychotic Agents; Catatonia; Cerebrovascular Disorders; Depression, Postpartum; Electroco | 2013 |
The challenges of clinical psychopharmacological management.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Community Mental Health Services; Comorbidity; Coopera | 2012 |
Neurologic soft signs in schizophrenic patients treated with conventional and atypical antipsychotics.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Haloperidol; Humans; Male; Nervous System D | 2005 |